In July 2019, CPQCC will launch a maternal substance exposure data collection pilot to improve understanding of this critical public health issue. By collecting data on all maternal substance exposures (including but not limited to opioids), we aim to improve healthcare for exposed newborns by focusing on treatment and length of stay in the hospital. This data will be used to drive improvement in the care provided to exposed infants through a range of reports designed to help hospitals identify areas of high and low performance, monitor the effects of improvement interventions, and conduct research that advances the quality of care.
Data collection on maternal exposures is overseen by our Maternal Exposure Workgroup which is comprised of member hospitals who are passionate about this topic. The workgroup is led by co-chairs Robert Castro, Lisa Chyi, and Angela Huang.
- Is optional and open to both CPQCC member and non-member hospitals
- Will be NICU focused but will not be limited to the NICU (in other words, data may also be collected on babies in the Well Baby Nursery who have been exposed to drugs in utero). No identifying data about the mother will be collected.
- Will be housed on the NICU Data site
- Is separate from the Mother & Baby Substance Exposure Initiative, which CPQCC is implementing in partnership with CMQCC and Health Management Associates in select counties across California. Hospitals that have been recruited to participate in the Mother & Baby Substance Exposure Initiative from the selected counties are strongly encouraged to also participate in the Maternal Substance Exposure Data Collection Pilot. Hospitals which are not part of the Mother & Baby Substance Exposure Initiative, including non-CPQCC member hospitals, are also strongly encouraged to join the data collection pilot.
- Supporting materials and additional resources will be posted on this page when available.